Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Clinical trial NCT00022581 · COMPLETED

Trial details

NCT number: NCT00022581
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Small Lymphocytic Lymphoma

Start date: 2001-07-01
Primary completion: 2004-12-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.